Seven lessons for Australia from the recent Dutch epidemic
Q fever (Coxiella burnetii infection) is a common zoonosis in Australia, especially in rural Queensland and New South Wales.1 However, the largest outbreak of Q fever ever identified was in the Netherlands in 2007–2010, with about 4000 people affected.2 While further research is needed on best practice to control transmission, detect and treat infection, and monitor acute cases for the early detection of chronic Q fever, lessons have already emerged for Australian medical and public health practitioners.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Gidding HF, Wallace C, Lawrence GL, McIntyre PB. Australia’s national Q fever vaccination program. Vaccine 2009; 27: 2037-2041.
- 2. Roest HIJ, Tilburg JJHC, van der Hoek W, et al. The Q fever epidemic in the Netherlands: history, onset, response and reflection. Epidemiol Infect 2011; 139: 1-12.
- 3. Dijkstra F, van der Hoek W, Wijers N, et al. The 2007–2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol 2012; 64: 3-12.
- 4. Schimmer B, Ter Schegget R, Wegdam M, et al. The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis 2010; 10: 69.
- 5. Massey PD, Irwin M, Durrheim DN. Enhanced Q fever risk exposure surveillance may permit better informed vaccination policy. Commun Dis Intell 2009; 33: 41-45.
- 6. Kampschreur LM, Dekker S, Hagenaars JCJP, et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 2012; 18: 563-570.
- 7. Limonard GJM, Nabuurs-Franssen MH, Weers-Pothoff G, et al. One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection 2010; 38: 471-477.
- 8. van der Hoek W, Versteeg B, Meekelenkamp JCE, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 2011; 52: 1431-1436.
- 9. van der Hoek W, Meekelenkamp JCE, Leenders ACAP, et al. Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in the Netherlands. BMC Infect Dis 2011; 11: 44.
- 10. Carcopino X, Raoult D, Bretelle F, et al. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007; 45: 548-555.
- 11. Morroy G, Peters JB, van Nieuwenhof M, et al. The health status of Q-fever patients after long-term follow-up. BMC Infect Dis 2011; 11: 97.
- 12. National Health and Medical Research Council. The Australian Immunisation Handbook. 9th ed. Canberra: NHMRC, 2008.
- 13. Parker N, Robson J, Bell M. A serosurvey of Coxiella burnetii infection in children and young adults in South West Queensland. Aust N Z J Public Health 2010; 34: 79-82.
- 14. Maltezou HC, Raoult D. Q fever in children. Lancet Infect Dis 2002; 2: 686-691.
Heather Gidding is funded by a National Health and Medical Research Council postdoctoral research scholarship.
Stephen Graves is the Founder and Director of the Australian Rickettsial Reference Laboratory (ARRL). This is a not-for-profit diagnostic and research laboratory that receives money from the federal government (through “bulk-billing”) for diagnostic testing for Q fever. Any “profits” go into the ARRL research program. Stephen Graves does not receive any income from the ARRL.